B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Vidarabine

299 PubMed studies analyzed · 24 RCTs · Evidence Score: 46.4

Research Domains

Vidarabine has been studied across 12 research domains including 🛡️ Immunity, 🔬 Oncology, 🫘 Kidney, ✨ Skin & Hair, ❤️ Cardiovascular. The primary research focus is 🛡️ Immunity with 13% of studies addressing this area.

Loading evidence profile...

This evidence profile for Vidarabine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.